Secondary Analyses of Existing Datasets of Tobacco Use and Health
The National Institutes of Health and the Food and Drug Administration (FDA) invite R21 applications to the Secondary Analyses of Existing Datasets of Tobacco Use and Health program supporting the innovative analyses of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the FDA’s Center for Tobacco Products. Multiple awards of up to $275,000 each may be made.
Deadline: October 8, 2021